Executive Director, Clinical R&D
F2G, Ltd.
Princeton, New Jersey, United States
Disclosure(s): F2G Ltd: Employee
95 - Novel Antifungal Olorofim Use in Intractable CNS and Non-CNS Disseminated Coccidioidomycosis
Thursday, October 17, 2024
11:00 AM – 11:15 AM US PT